Pharmaceutical | The Hedge Connection Blog

Moderna Procures Machine Learning Partnership to Boost Generative AI Use In Drug Discovery Apr25

Posted 2:59 pm by McAlinden Research Partners & filed under AI, Daily Intelligence Briefing, Pharmaceutical.

The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on Pharmaceutical

GLP-1 Obesity Drugs Likely to Have Significant Impact on Biopharma Share Prices and Non-Healthcare Sectors Feb29

Posted 1:47 pm by McAlinden Research Partners & filed under Daily Intelligence Briefing, Pharmaceutical.

The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on Obesity Drugs

Pfizer and Moderna Look to Put COVID Bust Behind Them, Add New Drug Development to Pipelines Oct19

Posted 4:46 pm by McAlinden Research Partners & filed under Daily Intelligence Briefing, Pharmaceutical.

The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on Pharmaceuticals

Psychedelics Break New Ground in Clinical Trials, Research to be Bolstered by Key FDA Guidance Jul14

Posted 2:30 pm by McAlinden Research Partners & filed under Agriculture, Daily Intelligence Briefing, Pharmaceutical.

The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on psychedelic medicine

Another Blockbuster Biopharma Acquisition on Deck, May Set the Stage for Breakout M&A Activity in 2023 Dec2

Posted 7:26 pm by McAlinden Research Partners & filed under Daily Intelligence Briefing, Pharmaceutical.

The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on BioPharma

Posts Categorized: Pharmaceutical

Moderna Procures Machine Learning Partnership to Boost Generative AI Use In Drug Discovery Apr25

GLP-1 Obesity Drugs Likely to Have Significant Impact on Biopharma Share Prices and Non-Healthcare Sectors Feb29

Pfizer and Moderna Look to Put COVID Bust Behind Them, Add New Drug Development to Pipelines Oct19

Psychedelics Break New Ground in Clinical Trials, Research to be Bolstered by Key FDA Guidance Jul14

Another Blockbuster Biopharma Acquisition on Deck, May Set the Stage for Breakout M&A Activity in 2023 Dec2

SHARE THIS ARTICLE